Abstract:Background: Diabetes, associated with hyperlipidemia and oxidative stress, would lead to an increased production of reactive oxygen species. Rehmannia glutinosa (Di Huang) is widely used to nourish yin, invigorate the kidney (shen), and treat xiao ke (a diabetes-like syndrome in Chinese medicine). This study aims to investigate the antidiabetic and antioxidant effects of catalpol from R. glutinosa on rat diabetes induced by streptozotocin (STZ) and high-fat, high-sugar feed.Methods: Rats (eight rats in each group at least) were induced diabetes by an initial high-fat high-sugar feed for 3 weeks, followed by an intraperitoneal injection of STZ (30 mg/kg) for 3 days, and rats were fasted overnight before treatments. Catalpol at a dose of 0, 5, 10, 20 or 50 mg/kg was administrated through bolus intravenous injection to the experimental rats to find the most effective anti-hyperglycemic dose of catalpol to further study body weight loss, water intake, and food intake. The most effective catalpol dose was given to the diabetic model rats with hyperlipidemia, and the levels of blood sugar, plasma total cholesterol (TC), triglyceride (TG), and high-density lipoprotein cholesterol (HDL-C) were measured after catalpol administration once a day for 2 weeks. An oral glucose challenge test (OGCT) was performed after above experiments in which the most effective dose of catalpol has been determined. Levels of glutathione peroxidase (GSH-PX), catalase (CAT), superoxide dismutase (SOD), and malondialdehyde (MDA) were measured by corresponding reagent kits and morphological changes of the pancreas were observed with histopathological examination using H&E stain.Results: Catalpol at a dose of 50 mg/kg ameliorated body weight loss and increased water and food intake. Catalpol also attenuated the increase of plasma TC (P = 0.0067) and TG (P = 0.0084) and increased HDL-C (P = 0.0336). The OGCT revealed that catalpol reduced the increase of plasma glucose. The activities of antioxidative enzymes (SOD, P = 0.0037; GSH-PX, P = 0.0066; CAT, P = 0.005) were enhanced and MDA was reduced (P = 0.003). Furthermore, catalpol reduced the morphological impairment of the pancreas.Conclusion: Catalpol protected against STZ-induced diabetes with high-fat and high-sugar feed with ameliorated structural impairment of the pancreas and restored balance between oxidative enzymes and antioxidative enzymes.

Antidiabetic and Antioxidant Effects of Catalpol Extracted from Rehmannia Glutinosa (di Huang) on Rat Diabetes Induced by Streptozotocin and High-Fat, High-Sugar Feed

Protective effects and possible mechanisms of catalpol against diabetic nephropathy in animal models: a systematic review and meta-analysis

Hypoglycemic Effect of Catalpol on High-Fat Diet/streptozotocin-Induced Diabetic Mice by Increasing Skeletal Muscle Mitochondrial Biogenesis

Protective effect on pancreatic β cells of α-glucosidase inhibitors screened from Rehmannia glutinosa

The Active Ingredient Catalpol in Rehmannia Glutinosa Reduces Blood Glucose in Diabetic Rats Via the AMPK Pathway

Catalpol Ameliorates High-Fat Diet-Induced Insulin Resistance and Adipose Tissue Inflammation by Suppressing the JNK and NF-κB Pathways.

Therapeutic effect of catalpol on type 2 diabetic mice induced by STZ and high-fat diet and its possible mechanism

Hypoglycaemic Effect of Catalpol in a Mouse Model of High-Fat Diet-Induced Prediabetes

Amelioration of Diabetic Mouse Nephropathy by Catalpol Correlates with Down-Regulation of Grb10 Expression and Activation of Insulin-Like Growth Factor 1 / Insulin-Like Growth Factor 1 Receptor Signaling

Catalpol Weakens Depressive-like Behavior in Mice with Streptozotocin-induced Hyperglycemia via PI3K/AKT/Nrf2/HO-1 Signaling Pathway

Ganoderma Lucidum Polysaccharides Exert Anti-Hyperglycemic Effect On Streptozotocin-Induced Diabetic Rats Through Affecting Beta-Cells

Catalpol protects glucose-deprived rat embryonic cardiac cells by inducing mitophagy and modulating estrogen receptor.

Catalpol Ameliorates Neointimal Hyperplasia in Diabetic Rats

Catalpol improves insulin resistance and lipid metabolism disorder in diabetic mice by inhibiting microRNA-101-3p to up-regulate FOS-related antigen 2

Mitochondrial Fusion/fission Process Involved in the Improvement of Catalpol on High Glucose-Induced Hepatic Mitochondrial Dysfunction

Influence of Antioxidant Supplementation on High Fat Diet-Streptozotocin (HFD-STZ) Induced Type 2 Diabetes Mellitus in Albino Rats

Catalpol Ameliorates Sodium Taurocholate-Induced Acute Pancreatitis In Rats Via Inhibiting Activation Of Nuclear Factor Kappa B

The Hypoglycemic Mechanism of Catalpol Involves Increased AMPK-mediated Mitochondrial Biogenesis

Further pharmacological evidence of the neuroprotective effect of catalpol from Rehmannia glutinosa

Effects of Chinese Medicine Tongxinluo on Hyperglycemia and Beta-Cell Damage in Streptozotocin-Induced Diabetic Rats.

A Prescribed Chinese Herbal Medicine Improves Glucose Profile And Ameliorates Oxidative Stress In Goto-Kakisaki Rats Fed With High Fat Diet